INS and diabetes mellitus: We verified whether this conclusion could be extended to other autoantigens of islet proteins, as well as to newly discovered peptides of insulin targeted by reactive T-cells in human diabetes, such as the hybrid insulin products (HIPs)29,42 and the defective immunogenic peptide translated from the insulin mRNA39.